Akhigbe RE

No ORCID on file · 5 papers in corpus
2026
Current evidence and emerging approaches in immunotherapy for gynecological cancers.
Discover oncology ·doi:10.1007/s12672-026-04785-9

Gynecological cancers, such as vulvar, cervical, endometrial, and ovarian cancers, are the leading causes of morbidity and mortality among women globally. Conventional management modalities like chemotherapy, surgery, and radiotherapy have …

review 2025
Corrigendum to "Comparison of effectiveness of the levonorgestrel intrauterine system and dienogest in the management of adenomyosis: A systematic review and meta-analysis" [Eur. J. Obstetr. Gynecol. Reprod. Biol. 300 (2024) 230-239]
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2025.114024
review 2025
Re: Letter to the editor: Comparison of the effectiveness of levonorgestrel intrauterine system and dienogest in the management of adenomyosis: A systematic review and meta-analysis
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2025.02.011
meta-analysis 2024
Comparison of the effectiveness of levonorgestrel intrauterine system and dienogest in the management of adenomyosis: A systematic review and meta-analysis
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2024.07.038

BACKGROUND: Adenomyosis is a gynaecological lesion that impairs female fertility and contributes to reduced quality of life. There are several surgical and medical options for the management of this lesion; however, women who wish to concei…

2024
Gut microbiota-gonadal axis: the impact of gut microbiota on reproductive functions.
Frontiers in immunology ·doi:10.3389/fimmu.2024.1346035

The influence of gut microbiota on physiological processes is rapidly gaining attention globally. Despite being under-studied, there are available data demonstrating a gut microbiota-gonadal cross-talk, and the importance of this axis in re…